Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemastine in Cardiovascular Surgery
NCT03826004Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Feb 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in anaphylaxis comparing Clemastine with Placebo (2 arms). Primary endpoint: Histamine concentration in plasma. Started Feb 2019; status: completed.
02
Drugs
clemastine
03
Conditions
anaphylaxis
Beyond the preview
Go deeper on NCT03826004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03826004.